Preoperative Chewing Gum and Postoperative Nausea and Vomiting
Launched by MIN SUK CHAE · May 31, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of chewing gum before robotic surgery on reducing nausea and vomiting after the surgery. Postoperative nausea and vomiting (PONV) is a common issue that can make recovery uncomfortable and prolong hospital stays. The trial aims to see if chewing gum can help improve bowel movement and decrease these symptoms, potentially helping patients recover faster and go home sooner.
To participate in the trial, you must be a woman aged between 19 and 69 who is scheduled for elective robotic surgery and has a low risk according to a specific health classification. Unfortunately, if you have certain dental issues, a history of jaw problems, or are undergoing emergency surgery, you won’t be eligible. If you join the trial, you’ll be asked to chew gum before your surgery, and researchers will monitor how this affects your recovery. This study is not yet recruiting participants, but it's an exciting opportunity to explore new ways to improve the surgical experience for patients.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Adult patients aged 19 to under 70 years
- • 2. Scheduled elective robotic surgery
- • 3. American Society of Anesthesiologists (ASA) Physical Status Classification I or II
- Exclusion Criteria:
- • 1. Cases where robotic surgery was planned but suddenly converted to another type of surgery
- • 2. Patients with a history of dental damage, dentures, loose or capped teeth, or other unstable dental conditions
- • 3. Patients with a history of temporomandibular joint (TMJ) damage or surgery
- • 4. Head and neck surgeries
- • 5. Emergency surgeries
- • 6. Refusal to participate in the study
About Min Suk Chae
Min Suk Chae is a dedicated clinical trial sponsor committed to advancing medical research and innovation through rigorous and ethical study designs. With a focus on enhancing patient outcomes, the organization collaborates with healthcare professionals and research institutions to conduct comprehensive clinical trials across various therapeutic areas. By prioritizing safety, efficacy, and regulatory compliance, Min Suk Chae aims to contribute valuable insights to the scientific community and improve healthcare solutions for diverse populations. Their expert team is driven by a mission to facilitate the development of novel therapies that address unmet medical needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported